Reply to 'Comment on 'Efficacy and toxicity of treatment with the anti-CTLA-4 antibody ipilimumab in patients with metastatic melanoma after prior anti-PD-1 therapy''.

Thumbnail
View/Open
Publication Date
2017-04-11
ICR Author
Author
Bowyer, S
Prithviraj, P
Lorigan, P
Larkin, J
McArthur, G
Atkinson, V
Millward, M
Khou, M
Diem, S
Ramanujam, S
Kong, B
Liniker, E
Guminski, A
Parente, P
Andrews, MC
Parakh, S
Cebon, J
Long, GV
Carlino, MS
Klein, O
Type
Journal Article
Metadata
Show full item record
URL
https://repository.icr.ac.uk/handle/internal/636
Collections
Licenseref URL
http://www.rioxx.net/licenses/all-rights-reserved
Version of record
Research team
Melanoma and Kidney Cancer
Language
eng
License start date
2017-04-11
Citation
Br J Cancer, 2017, 116 (8), pp. e15 - ?